Brief: Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program To Accelerate Market Access To Alpha Dart® For Patients With Recurrent Glioblastoma Multiforme

Alpha Tau Medical

21/10/2024 16:31

Oct 21 (Reuters) - Alpha Tau Medical Ltd  DRTS.O :
    * ALPHA TAU ANNOUNCES ACCEPTANCE INTO FDA’S TOTAL PRODUCT
LIFE
CYCLE ADVISORY PROGRAM TO ACCELERATE MARKET ACCESS TO ALPHA
DART® FOR PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME

Source text for Eikon:  ID:nGNX2Kf9Zb 
Further company coverage:  DRTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))